NASDAQ:AKCA
Delisted
Akcea Therapeutics, Inc. Stock News
$18.17
+0 (+0%)
At Close: May 27, 2022
Personalis (PSNL) Gets a Buy Rating from Oppenheimer - Markets
04:19pm, Wednesday, 24'th Jun 2020
Oppenheimer analyst Kevin DeGeeter assigned a Buy rating to Personalis (PSNL – Research Report) today and set a price target
Emma Roberts & Jack Whitehall To Star In ‘Robots’ Movie – Cannes
02:05am, Wednesday, 24'th Jun 2020
We’re The Millers and American Horror Story actress Emma Roberts is attached to star with UK comedian Jack Whitehall in Robots, a comedy feature in which a womanizer and a gold digger learn h…
Osmotica Pharmaceuticals (OSMT) in Focus: Stock Moves 6.7% Higher
12:46pm, Tuesday, 23'rd Jun 2020
Osmotica Pharmaceuticals (OSMT) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Oppenheimer Maintains Their Buy Rating on Vascular Biogenics (VBLT) - Markets
12:42am, Tuesday, 23'rd Jun 2020
Oppenheimer analyst Kevin DeGeeter maintained a Buy rating on Vascular Biogenics (VBLT – Research Report) yesterday and set a price
Amicus Therapeutics (FOLD) Catches Eye: Stock Jumps 8.9%
01:23pm, Monday, 22'nd Jun 2020
Amicus Therapeutics (FOLD) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
Dynavax Technologies (DVAX) Jumps: Stock Rises 6.6%
01:06pm, Monday, 22'nd Jun 2020
Dynavax Technologies (DVAX) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Incyte (INCY) Looks Good: Stock Adds 8.3% in Session
12:36pm, Monday, 22'nd Jun 2020
Incyte (INCY) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
MannKind (MNKD) Looks Good: Stock Adds 5.5% in Session
12:30pm, Monday, 22'nd Jun 2020
MannKind (MNKD) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Better Buy: Biogen vs. Bristol Myers Squibb | The Motley Fool
01:03pm, Sunday, 21'st Jun 2020
Neither drugmaker has been a winner this year. But one appears to be a pretty safe bet to win in the future.
Mackenzie Financial Corp Acquires 8,500 Shares of Akcea Therapeutics Inc (NASDAQ:AKCA)
07:22am, Sunday, 21'st Jun 2020
Mackenzie Financial Corp grew its holdings in Akcea Therapeutics Inc (NASDAQ:AKCA) by 40.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commis
All You Need to Know About Akcea Therapeutics (AKCA) Rating Upgrade to Strong Buy
04:00pm, Friday, 19'th Jun 2020
Akcea Therapeutics (AKCA) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Epizyme Gets FDA Nod for Tazverik sNDA in Follicular Lymphoma
02:19pm, Friday, 19'th Jun 2020
The FDA grants approval to Epizyme's (EPZM) sNDA for lead drug,Tazverik, for two distinct follicular lymphoma indications.
Editas (EDIT) in Focus: Stock Moves 8.6% Higher
12:41pm, Friday, 19'th Jun 2020
Editas (EDIT) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
Deutsche Bank AG Has $7 Million Stake in Ionis Pharmaceuticals Inc (NASDAQ:IONS)
06:26am, Friday, 19'th Jun 2020
Deutsche Bank AG decreased its position in shares of Ionis Pharmaceuticals Inc (NASDAQ:IONS) by 56.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities
BioNano Genomics (BNGO) Receives a Buy from Oppenheimer - Markets
01:33am, Friday, 19'th Jun 2020
In a report released yesterday, Kevin DeGeeter from Oppenheimer maintained a Buy rating on BioNano Genomics (BNGO – Research Report),
